TransCode Therapeutics Inc (RNAZ)

[Tahoe2468]

This is how I understand the proposal 4 [to grant the Board the authority to file an amendment to effect the reverse spilt in their discretion before Dec 31, 2024] see page 21-28 https://ir.transcodetherapeutics.com/static-files/2eab1bdd-3a8d-46a1-a1ad-8dfe8aa1770b 1. The primary reason for rs is to increase the stock price for the purpose of regaining $1 minimum bid requirement & raise investor interest (explained on page 22, see screen shot) 2. When the proxy material was written, the stock price was around $0.45, and the company needed a plan to increase the stock price when they appeal the decision to delist in the Hearing panel on May 14, imo. 3. On page 26, it states "The Reverse Stock Split will not be consummated, if at all, until after approval of our stockholders is obtained." So proposal 4 is to grant the Board authority to decide if R/S is needed, and if they deem so, there will be another vote [similar to last time]. Otherwise, if R/S not needed, such authority will expire by Dec 31, 2024 $RNAZ